1 year return (CAGR)
-61.82%
Processa Pharmaceuticals Inc Exchange (NASDAQ, USD)
PCSA
1.89
+0.05 (+2.72%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-78.16%
5 year return (CAGR)
-78.06%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
5.28M
Price/Sales
-
Ent value
7.47M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-59.59%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.90 |
| Daily high | 1.97 |
| Daily low | 1.86 |
| Daily Volume | 4K |
| All-time high | 116375.00 |
| 1y analyst estimate | 25.00 |
| Beta | 0.97 |
| EPS (TTM) | -4.89 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PCSA | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.29% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 23 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -93.52% | -10.68% |
| Avg time to new high | 1030 days | 12 days |
| Max time to new high | 2059 days | 1805 days |
News
